| DWP announces mesothelioma compensation system
John Hutton today gave details of how the system for compensating sufferers of mesothelioma, the debilitating form of lung cancer caused by exposure to asbestos, would be improved and speeded up. After working with key stakeholders, the Secretary of State for Work and Pensions said interim measures to speed up current claims would be put into action and he was determined to put in place a long-term solution. I am committed to ensuring sufferers of this awful disease, which progresses so rapidly from the time of diagnosis, will get compensation before they die, said Mr Hutton. There are a series of measures we... To continue reading this story please register for free breaking news from http://www.postmagazine.co.uk Username: Password: Remember me .
Mesothelioma Cancer specialist accuses NHS of putting money before lives
A leading cancer specialist accused the NHS yesterday of putting money before patients' lives after use of a drug effective in prolonging the lives of sufferers from the asbestos-linked lung cancer mesothelioma was blocked. A report by the National Institute for Health and Clinical Excellence (Nice) has concluded that the drug pemetrexed disodium - sold under the name Alimta - would not be recommended for use within the NHS. It stated that there was not enough evidence that the drug, which was used in trials with the anti-cancer drug cisplatin, was better than cheaper treatments. But Dr Robin Rudd, an expert in respiratory oncology and a former consultant at St Bartholomew's hospital, London, who quit the NHS in March over cost-cutting measures, claimed the decision had been taken solely on financial grounds.
Statins Reverse Doxorubicin Resistance in Mesothelioma Cells
NEW YORK JUL 12, 2006 (Reuters Health) - Statins reverse doxorubicin resistance in human malignant mesothelioma cells in culture, a finding that may lead to new clinical strategies to improve doxorubicin efficacy in this hard to treat cancer. "The mechanism of statin-mediated inhibition of small G-protein function is the molecular basis of the drug-elicited reversion of doxorubicin resistance in human malignant mesothelioma cells," Dr. Amalia Bosia from University of Torino, Italy told Reuters Health. Dr. Bosia and colleagues investigated the ability of statins to reverse resistance to doxorubicin in drug-resistant primary human malignant mesothelioma cells and the molecular mechanism behind the reversion, according to their report in the July 1st issue of the International Journal of Cancer.
OSHA Advisory: Asbestos Automotive Brake and Clutch Repair Work
OSHA is issuing this Safety and Health Information Bulletin to inform employees and employers in the automotive brake repair industry of the precautions that must be taken when working with automotive brakes and clutches containing asbestos. In the case of do-it-yourselfers*, OSHA does not have jurisdiction, and OSHA does not require theses practices to be followed. To reduce the potential exposure to asbestos, EPA strongly recommends that all automotive brake and clutch repair work be done by professional auto mechanics. Although the use of asbestos in friction products is declining annually, it remains a substantial source of potential exposure. In addition, there is still potential exposure to asbestos contained in automotive brakes and clutches on older vehicles in need of service.
|
